Assessment of Self – Reported Adverse Drug Reactions to COVID – 19 Vaccines in Undergraduate Students of a Tertiary Care Hospital, Tamil Nadu, India
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.225 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Shakthi Priya P. und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The COVID-19 pandemic has resulted in significant global mortality and morbidity and necessitated rapid vaccine development and deployment. With researchers' efforts, the vaccines were manufactured, and the largest possible population was immunised. Due to widespread use, mild-to-moderate reactions have been observed and analysed in prior studies, but inadequate data on reporting rates and on awareness of reporting methods, particularly among individuals who experienced ADRs, highlighted a gap that the present study addressed.
Objectives
To determine the ADR reporting rate and assess the behaviour of ADR affected vaccine recipients. To analyse the severity of reported adverse drug reactions. Materials and Methods: Following IEC approval, a cross-sectional design was conducted at a rural tertiary care hospital in the Chengalpattu district between November 2025 and January 2026, among second-year MBBS and BDS students. Data on adverse drug reactions were collected using validated questionnaires distributed via Google Forms to the study participants, and all ethical norms were followed to maintain data secrecy.
Results
The data were analysed using descriptive statistics. A total of 151 students participated in the study, with the top 3 adverse reactions being fever, pain, and myalgia. More than 80% developed ADRs within the first 24 hours; 57 individuals experienced a reaction with the first dose, and 9.4% reported ADRs. Only 4 participants required hospitalisation, confirming that the reactions were mild to moderate in severity.
Conclusion
The current study demonstrated that immunisations are predominantly safe. However, mild-tomoderate responses were relatively frequent. Underreporting of vaccine-related ADRs is a significant issue that requires targeted educational campaigns.
Zitieren
APA
P., S. P., C., S. V., & Vishwasrao, S. M. (2026). Assessment of Self – Reported Adverse Drug Reactions to COVID – 19 Vaccines in Undergraduate Students of a Tertiary Care Hospital, Tamil Nadu, India. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.225
Vancouver
P. SP, C. SV, Vishwasrao SM. Assessment of Self – Reported Adverse Drug Reactions to COVID – 19 Vaccines in Undergraduate Students of a Tertiary Care Hospital, Tamil Nadu, India. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.225
BibTeX
@article{P2026,
author = {P., Shakthi Priya and C., Sangeetha V. and Vishwasrao, Sunil M.},
title = {Assessment of Self – Reported Adverse Drug Reactions to COVID – 19 Vaccines in Undergraduate Students of a Tertiary Care Hospital, Tamil Nadu, India},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.225}
}
EUVIMED